(Q34571817)

3 August 2017

1 reference

title

Haemopoietic stem-cell transplantation: recent progress and future promise (English)

1 reference

stem cell transplantation

3 August 2017

main subject

1 reference

C Craddock

1

1 reference

3 August 2017

publication date

1 December 2000

1 reference

Lancet Oncology Commission

3 August 2017

published in

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

page(s)

227-234

1 reference

Human stem cell assays in immune-deficient mice

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

A newly discovered class of human hematopoietic cells with SCID-repopulating activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Tolerance of allogeneic heart grafts in mice simultaneously reconstituted with purified allogeneic hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Developments in allogeneic peripheral blood progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

High-dose therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Effect of HLA mismatches on the outcome of hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2800%2900153-4

7 January 2021

10.1016/S1470-2045(00)00153-4

Identifiers

DOI

1 reference

3 August 2017

1 reference